Tonsils

Tonsils: Anatomy, Immunology, Conditions, and Supportive Interventions

Overview and Definition

The tonsils are a set of lymphoid organs facing into the aerodigestive tract, which is known as Waldeyer's tonsillar ring, and consist of the adenoid tonsil (or pharyngeal tonsil), two tubal tonsils, two palatine tonsils, and the lingual tonsils. When used unqualified, the term most commonly refers specifically to the palatine tonsils, which are two lymphoid organs situated at either side of the back of the human throat. Scientifically, tonsils are part of the lymphatic system and are classified as secondary lymphoid organs.

The lymphoid tissue of Waldeyer's ring is located at the gateway of the respiratory and alimentary tract and belongs to the mucosa-associated lymphoid tissue (MALT). Tonsils are key components of the immune system, acting as the body's first line of defense against inhaled or ingested pathogens. Located at the entrance of the respiratory and digestive tracts, they monitor and respond to microbes by initiating immune responses.

Anatomy and Components

Waldeyer's Tonsillar Ring

The palatine tonsils, adenoids, tubal tonsils, and lingual tonsils are lymphoepithelial tissues that make up the components of Waldeyer's ring, named after the German anatomist Heinrich Wilhelm Gottfried von Waldeyer-Hartz. Heinrich Wilhelm Gottfried von Waldeyer-Hartz first described the incomplete ring of lymphoid tissue, situated in the naso-oropharynx, in 1884.

Waldeyer's ring includes the following four structures: (1) the pharyngeal tonsil, located at the midline along the roof and posterior wall of the nasopharynx; (2) the tubal tonsils (also known as Gerlach tonsils), located on either lateral nasopharyngeal wall immediately posterior to the Eustachian tube orifice and in close association with the torus tubarius; (3) the palatine tonsils, located along each lateral oropharyngeal wall between the anterior and posterior tonsillar pillars; (4) the lingual tonsils, located along the base of tongue and contiguous with the palatine tonsils at the glossotonsillar sulcus.

The Palatine Tonsils

The palatine tonsils are two compact bodies of lymphoid tissue located laterally between the opening of the mouth and the pharynx. The palatine tonsils are the largest bodies of lymphoid tissue in Waldeyer's ring. They are located within the tonsillar bed of the lateral oropharynx wall — between the palatoglossal arch (anteriorly) and palatopharyngeal arch (posteriorly). The tonsillar fossa is composed of three muscles: the palatoglossus, which forms the anterior tonsillar pillar; the palatopharyngeus, which is the posterior tonsillar pillar; and the superior constrictor muscle of the pharynx, which forms the tonsillar bed.

Histologically, tonsils contain lymphoid follicles with germinal centers where B cells undergo affinity maturation. They are covered by stratified squamous epithelium, and the tissue harbors a dense population of dendritic cells, T lymphocytes, and macrophages, creating a potent mucosal immune interface. The mucosa covering the palatine tonsils is thrown into numerous crypts — about 6–20 in each tonsil. These crypts serve to increase the surface area of mucosa covering the tonsil. The palatine tonsils receive their arterial supply primarily from the tonsillar branch of the facial artery, while venous drainage occurs via the external palatine vein. The tonsillar fossa is innervated by the tonsillar branches of the glossopharyngeal nerve and branches of the lesser palatine nerves.

The Pharyngeal Tonsil (Adenoid)

The pharyngeal tonsil (or "adenoid") is located on the roof of the nasopharynx, under the sphenoid bone. To facilitate exposure and trapping of antigens, the mucosa covering the adenoid is thrown into grooves called furrows. These furrows serve to increase the surface area of the adenoid tissue.

The Tubal Tonsils

The palatine tonsils, nasopharyngeal tonsil (adenoid), and lingual tonsil constitute the major part of Waldeyer's ring or nasal-associated lymphoid tissue (NALT), with the tubal tonsils and lateral pharyngeal bands as less prominent components. The tubal lymphoid structures are lined by respiratory epithelium, and crypts are present and infiltrated by lymphatic tissue. Gerlach's tonsils receive arterial blood by branches of the sphenopalatine and the ascending pharyngeal arteries. Lymphatic drainage is achieved via the retropharyngeal and the deep cervical lymph nodes.

The Lingual Tonsil

The lingual tonsil is located in the submucosa of the posterior third of the tongue and forms the inferior part of Waldeyer's ring. Its epithelium is stratified non-keratinised squamous epithelium.

Cellular Composition

The tonsils are immunologically active lymphatic organs. The lymphocytes of tonsil tissues are approximately composed of 60 percent B lymphocytes and 40 percent T lymphocytes. The epithelium covering these lymphoid structures contains specialized cells, such as M cells and intraepithelial lymphocytes, which contribute to the immune surveillance of luminal antigens.

Physiological Functions

Antigen Sampling and Immune Initiation

Their primary function is to participate in the secondary immune system by immunologically sampling antigens and local pathogens. They are strategically located at the junction of the respiratory and digestive tracts to be able to serve as a site for continued lymphoid stimulation. Specialized antigen-capturing cells, known as M cells, are present on the tonsillar surface and facilitate the uptake of microbial antigens. After antigen recognition, M cells stimulate resident T cells.

Captured antigens are presented to B and T cells within the tonsil, then the B cells migrate to germinal centers within the tonsil as an adaptive immune response is initiated. Tonsil crypts are able to trap foreign material and transport it to lymphoid follicles. When stimulated by antigens, B cells can proliferate in the germinal centers of the tonsils and produce all five major antibody classes.

Antibody Production and Immunological Memory

Adenoids and tonsils participate in the generation of adaptive immune responses. B cells within germinal centers undergo class switch recombination and somatic hypermutation, resulting in the production of high-affinity antibodies. T cells recognize and eliminate infected cells, thus limiting the dissemination of pathogens. Additionally, adenoids and tonsils contribute to the development of immune memory, promoting faster and more efficient immune responses upon re-exposure to previously encountered pathogens.

B cells are predominant in tonsillar germinal centers and secrete IgG and IgA. Contact with allergens in the upper respiratory tract enhances local immunity and also contributes to the development of systemic immunity. The generation of B cells in the germinal centers of the tonsil is one of the most essential tonsillar functions.

Mucosal Immunity and the MALT System

The pharyngeal and palatine tonsils are compact yet physiologically complex mucosa-associated lymphoid tissues that make up a portion of Waldeyer's ring. As part of the mucosal immune system, these structures function in exogenous antigen sampling and stimulation of immune responses. Composed primarily of B-cell lymphoid tissue, the tonsils support mucosal secretory immunity.

Developmental Activity

The immunologic activity of the tonsils and the adenoids in Waldeyer's ring helps protect the entire upper aerodigestive tract. Tonsils are most immunologically active between the ages of four and ten. Evidence exists that suggests that tonsils may play a role in T cell maturation and development like the thymus does, but more research is needed.

Clinical Assessment of Tonsil Health

Physical Examination

To diagnose conditions related to the tonsils, a healthcare provider will examine the throat for redness and swelling and ask about other symptoms such as fever, cough, runny nose, rash, or stomachache. Clinicians also assess the degree of tonsillar enlargement using standardized grading scales.

Tonsillar Size Grading: The Brodsky Scale

The Brodsky scale is the most common system used today and is based on how much of the "oropharyngeal airway" (the space between the tonsil pillars) is occupied by the tonsils. It ranges from Grade 0 to Grade 4. Grade 1 means the tonsils fill less than 25% of the space, while Grade 4 represents "kissing tonsils," where they fill more than 75% of the area and often touch each other in the middle.

The Brodsky grading scale demonstrates the highest interobserver reliability (ICC 0.721) and intraobserver reliability (0.954) compared to other scales, making it the preferred method for clinical assessment of tonsil size. The Brodsky scale grades tonsils from 0–4 based on the percentage of oropharyngeal airway obstruction. Objective tonsil measurements (length, width, height, weight, volume) correlate significantly with subjective tonsil grading but are more meaningful in predicting the severity of sleep-disordered breathing (SDB). When there is discordance between tonsillar size on physical examination and reported severity of SDB, polysomnography (PSG) should be advocated to clarify diagnosis and guide treatment decisions.

Throat Culture and Rapid Antigen Testing

Tonsillitis and peritonsillar abscess are clinical diagnoses. Testing is indicated when group A beta-hemolytic Streptococcal (GABHS) infection is suspected. When bacterial infection is confirmed or strongly suspected, appropriate antibiotic treatment is indicated to reduce the risk of serious downstream complications.

Polysomnography

Polysomnography is recommended in patients with sleep-disordered breathing without comorbidities and in patients younger than two years or with specific disorders such as obesity, Down syndrome, or craniofacial disorders. Tonsillar size alone should not dictate surgical intervention; clinicians must assess for obstructive sleep-disordered breathing symptoms including snoring, witnessed apneas, growth retardation, enuresis, behavioral problems, and poor school performance.

Guidelines for Surgical Intervention (Tonsillectomy)

The American Academy of Otolaryngology–Head and Neck Surgery (AAO–HNS) has updated its guideline on tonsillectomy indications and perioperative care in children one to 18 years of age. Tonsillectomy may be recommended for recurrent throat infection if there have been seven episodes in the past year, at least five episodes per year for two years, or at least three episodes per year for three years, with documentation in the medical record for each episode and at least one of the following: temperature above 101°F (38.3°C), cervical adenopathy, tonsillar exudate, or positive test for group A beta-hemolytic streptococcus.

"Tonsillectomy in children who do not meet these criteria (known as the Paradise Criteria) does not provide clinically meaningful improvements in outcomes, is not cost-effective and exposes children to unnecessary risks of surgery."

Clinicians should assess the patient with recurrent throat infection who does not meet standard frequency criteria for modifying factors that may nonetheless favor tonsillectomy, which may include but are not limited to multiple antibiotic allergy/intolerance, PFAPA (periodic fever, aphthous stomatitis, pharyngitis, and adenitis), or history of peritonsillar abscess.

Conditions and Concerns Associated with the Tonsils

Acute Tonsillitis

Tonsillitis is inflammation of the palatine tonsils. The inflammation usually extends to the adenoid and the lingual tonsils; therefore, the term pharyngitis may also be used. Most cases of bacterial tonsillitis are caused by group A beta-hemolytic Streptococcus pyogenes (GABHS). Common disorders associated with tonsils include acute tonsillitis, often caused by viral or bacterial infections, with recurrent cases frequently leading to tonsillectomy, especially in children.

Untreated or inadequately treated bacterial tonsillitis can lead to serious sequelae. If tonsillitis caused by streptococcal bacteria is not treated or if treatment is not completed, there is a higher risk of rare disorders such as rheumatic fever, which can affect the heart, joints, nervous system and skin; complications of scarlet fever; and swelling and irritation of the kidney, called poststreptococcal glomerulonephritis.

Recurrent Tonsillitis

Recurrent tonsillitis suggests that there may be some intrinsic defect either in the tonsils themselves or in the patient's immunity. IgA production in tonsillar B cells is markedly reduced in children with recurrent tonsillitis. Recurrent tonsillitis and chronic tonsil hypertrophy are the most common reasons for performing tonsillectomy in children.

Peritonsillar Abscess

Peritonsillar abscess is the most common deep neck space infection in adolescents and young adults and usually arises as a complication of acute tonsillitis or pharyngitis. A polymicrobial flora is isolated from peritonsillar abscesses. Predominant organisms are the anaerobes Prevotella, Porphyromonas, Fusobacterium, and Peptostreptococcus species. Major aerobic organisms are GABHS, S. aureus, and H. influenzae. The abscess usually forms between the tonsil and the anterior pillar, causing pain, dysphagia, and drooling, and requires drainage. The prognosis for peritonsillar abscesses is generally favorable; however, delayed treatment and airway compromise can be fatal. Most patients recover within 4 to 7 days following prompt drainage and antibiotic therapy.

Adenotonsillar Hypertrophy and Obstructive Sleep Apnea

Hypertrophy of the tonsils and adenoids is the most common cause of pediatric obstructive sleep apnea. The most common causes of obstructive sleep apnea hypopnea syndrome in children include tonsil hypertrophy and adenoidal hypertrophy, among others. Together, tonsil and adenoidal hypertrophy account for over 85% of cases. Obstructive sleep apnea has severe effects on cognitive function, growth and development, and behavior of children, and life quality also significantly decreases.

As the palatine and pharyngeal tonsils undergo their initial rapid growth phase through antigen sampling, some individuals develop pathologic immune-related processes such as chronic adenoiditis or tonsillitis, recurrent otitis media, rhinosinusitis, and even allergic disease. Others develop complications associated with anatomic obstruction of the oropharynx and nasopharynx, such as sleep-disordered breathing/obstructive sleep apnea from adenotonsillar hypertrophy.

Tonsilloliths (Tonsil Stones)

Tonsil stones or tonsilloliths are calcifications of the debris in the tonsils, almost exclusively affecting palatine tonsils. Palatine tonsils have crypts and clefts which often entrap food particles, dead cells and bacteria. Over time, this debris can become mineralised into whitish concretions called tonsil stones or tonsilloliths. Tonsilloliths are usually small and recurrent and can be unilateral or bilateral. They are often asymptomatic. Symptoms, if present, can include throat irritation/discomfort, foreign body sensation in the throat, mild pain or heaviness in the throat with mild difficulty swallowing, and halitosis. Tonsilloliths usually do not require any treatment except routine warm saline gargles and maintaining oral hygiene. For larger tonsilloliths, or when symptoms are persistent, surgical options can alleviate the disease.

Tonsillar Malignancy

Cancer of the palatine tonsil accounts for between 2 and 10 percent of all head and neck cancers. Men are affected four times more frequently than women, with an age range between fifty and seventy. More than 70 percent of malignancies are squamous cell carcinomas, with lymphoma accounting for most other tonsil malignancies.

An important designation for tonsil cancer is the presence of HPV in the tumor. Because HPV is integral in the formation of some of these cancers, the presence of HPV type 16 (called p16 positive) in the tumor has an impact on the tonsil cancer stage. Conversely, if the tumor doesn't have HPV, it will be marked as p16 negative. Drinking alcohol, smoking, and having HPV appear to increase the risk of tonsil cancer.

PFAPA Syndrome

Among rarer tonsil-related conditions, PFAPA (Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis) is a recognized clinical entity. PFAPA is considered a modifying factor that may favor tonsillectomy in patients with recurrent throat infection who do not otherwise meet standard frequency criteria.

Nutrients, Herbs, and Natural Ingredients

The following section distinguishes traditional use from scientific evidence. No natural intervention covered here constitutes a replacement for established medical treatment of tonsil infections or their complications.

Vitamin D

Traditional Use: Vitamin D is not a traditional herbal remedy but is an essential nutrient synthesized endogenously via sunlight exposure and obtained through diet. Its immunological significance has been explored in modern medicine.

Scientific Evidence: A case-control study using Poisson regression found that for every single unit increase in vitamin D level, there was a 3.1% decrease in the number of tonsillitis episodes per year (OR = 0.969, 95% CI 0.962–0.975, p < 0.0001). The researchers concluded that vitamin D deficiency is associated with higher rates of recurrent acute tonsillitis, and called for future controlled trials to investigate the role of vitamin D supplementation in reducing the rate of recurrent tonsillitis.

A systematic review (2024) identified eleven observational studies with a total of 2,503 participants examining this association. Low vitamin D levels are associated with an increased incidence of upper respiratory tract infections. The proposed mechanism involves vitamin D's role in stimulating the synthesis of antimicrobial peptides. Macrophages use extracellular 25(OH)D to synthesize 1,25-dihydroxyvitamin D, which binds to the vitamin D receptor and stimulates the synthesis of antimicrobial peptides such as defensin and cathelicidin. These antimicrobial peptides are the main defense factors in the upper respiratory tract.

Preliminary data showed that serum 25-OH vitamin D levels are lower in patients with recurrent tonsillopharyngitis. Two randomized controlled trials reported that vitamin D supplementation is effective for prevention of upper respiratory tract infections. However, to determine the minimal serum vitamin D level necessary to protect against such infections, more cohort studies with a larger number of cases are needed. Overall, the evidence is observationally consistent but requires further randomized controlled trial confirmation for definitive supplementation recommendations in tonsil-specific disease.

Zinc

Traditional Use: Zinc-containing preparations and throat lozenges have been used in folk medicine across many cultures for symptomatic relief of sore throats and upper respiratory infections.

Scientific Evidence: Zinc is a nutrient found in various foods such as poultry, beef, oysters, nuts, and dairy products. It is important for helping wounds heal, making proteins and DNA, and plays a role in the functioning of taste buds. Zinc also plays a role in immune system health, and a deficiency can adversely affect immune function.

A systematic review including 82 eligible studies found that regular vitamin C supplementation (1 to 2 g/day) reduces the duration (in adults by 8%, in children by 14%) and the severity of the common cold. Regarding zinc, supplementation may shorten the duration of colds by approximately 33%, and patients may be instructed to try zinc within 24 hours of onset of symptoms. A clinical trial of a combination supplement also explored zinc's role in tonsillar disease specifically: a dietary supplement composed of honey, propolis, Pelargonium sidoides extract, and zinc (DSHPP) was evaluated in an open-label, randomized, and controlled study comparing DSHPP plus standard of care versus standard of care alone for six days in children aged 3–10 years with acute tonsillopharyngitis. DSHPP plus standard of care showed better performance than standard of care alone for throat pain and erythema on day 6, swallowing on day 4, and total severity score on days 4 and 6 (p < 0.001). However, this was an open-label, combination-product trial; the independent contribution of zinc cannot be isolated from this study.

A systematic review by the NIH's Office of Dietary Supplements evaluating 39 randomized controlled trials on ingredients popular in immune-health supplements (including zinc) found that the evidence did not strongly support that taking these ingredients before getting sick would diminish the duration or severity of acute respiratory infection in otherwise healthy individuals. Evidence strength is therefore rated as moderate and contextual — more convincing for treatment initiated within 24 hours of symptom onset in confirmed upper respiratory illness than for prevention in healthy people.

Vitamin C

Traditional Use: Citrus-based remedies for sore throats and colds have been documented across European, Asian, and Indigenous traditions for centuries.

Scientific Evidence: Vitamins C and D, zinc, and Echinacea have evidence-based efficacy on immune system barriers including physical barriers, innate and adaptive immunity. Regarding vitamin C, regular supplementation (1 to 2 g/day) has shown that vitamin C reduces the duration (in adults by 8%, in children by 14%) and the severity of the common cold. Evidence is specifically for common cold duration and severity reduction rather than tonsillitis-specific outcomes. The benefit appears most consistent in individuals under physical stress. Evidence is rated moderate for cold symptom duration reduction, but tonsil-specific trials are lacking.

Echinacea (Echinacea purpurea and related species)

Traditional Use: Native American peoples, particularly Plains tribes, used Echinacea root and above-ground parts for a wide range of conditions including sore throats, toothaches, and infections. It was adopted into European phytotherapy in the 19th and 20th centuries.

Scientific Evidence: Regarding Echinacea, prophylactic treatment with this extract (2,400 mg/day) over 4 months appeared to be beneficial for preventing and treating the common cold. The current evidence of efficacy for zinc, vitamins D and C, and Echinacea is considered interesting enough that patients may be encouraged to try them for preventing or treating their colds, although further studies are needed.

For treatment, Echinacea purpurea is the most consistently useful variety; it was effective in 5 of 6 reviewed trials, likely owing to dose and formulation issues. However, a systematic review by NIH Office of Dietary Supplements researchers did not find strong evidence that ingredients such as Echinacea taken before getting sick would diminish the duration or severity of any acute respiratory infection in otherwise healthy consumers. Evidence is therefore rated preliminary to moderate, with the most consistent data for E. purpurea as a treatment (not prevention) of upper respiratory tract infections. No tonsillitis-specific clinical trials in high-quality isolation have been conducted.

Elderberry (Sambucus nigra)

Traditional Use: Black elderberry has been used for centuries in European traditional medicine for feverish conditions, upper respiratory infections, and as a diaphoretic. Preparations historically included syrups, infusions, and wines made from the berries or flowers.

Scientific Evidence: Of 27 ingredients analyzed in a systematic review of dietary supplement immune-health claims, only eight had peer-reviewed literature meeting eligibility criteria, and elderberry was among them. The review summarized the evidence for echinacea, elderberry, garlic, vitamins A, C, D, E, and zinc. Elderberry preparations have been investigated in upper respiratory tract infections, with some randomized controlled trials showing reduced cold duration and symptom severity, though evidence is considered preliminary. No high-quality clinical trials have specifically examined elderberry effects on tonsil tissue, tonsillitis severity, or tonsillar immune parameters.

Propolis

Traditional Use: Propolis, a resinous substance produced by honeybees, has been used since antiquity — documented in ancient Greek, Roman, and Egyptian medicine — for its wound-healing and antimicrobial properties. In folk medicine throughout Europe and the Middle East, propolis preparations have been applied to throat and oral mucosa complaints.

Scientific Evidence: Di Pierro et al. showed that a mixture of propolis-phytosome containing 75 mg/sachet of pure propolis was effective in an open-label, retrospective, controlled clinical study involving patients with nonstreptococcal and viral pharyngitis caused by paramyxoviruses, rhinoviruses, and adenoviruses. This product decreased the severity of symptoms such as sore throat, fever, and pharyngeal erythema.

A double-blind clinical trial involving young patients ranging from 5 to 12 years of age with viral and bacterial tonsillopharyngitis showed that the administration of a complex product containing honey, royal jelly, and propolis (20–40 mg/kg for 10 days) was beneficial in the treatment of upper respiratory tract infections. A preparation containing propolis (50 mg/mL), Echinacea (50 mg/mL), and vitamin C (10 mg/mL) was assessed in a randomized, double-blind, placebo-controlled study for preventing upper respiratory tract infections in children aged 1–5 years. This preparation was administered at doses of 5.0 mL and 7.5 mL twice daily for 12 weeks.

Because studies used multi-ingredient preparations, the independent contribution of propolis to tonsillar outcomes cannot be isolated. Evidence for propolis in throat/tonsillar infections is rated preliminary, with open-label or combination-product design being the main limitation.

Honey

Traditional Use: Honey has been used for sore throats across diverse traditions, including Ayurveda, traditional Chinese medicine, and European folk medicine, historically prepared as warm drinks, gargles, or combined with lemon juice and herbs.

Scientific Evidence: A systematic review examined the effectiveness of honey as a natural therapy for the management of sore throat. The main objective was to systematically review the supporting evidence regarding the use, effectiveness, and potential mechanisms of honey as a natural remedy for managing the sore throat. As noted above, honey was also a component in the randomized, controlled trial of a combination supplement in children with acute tonsillopharyngitis. DSHPP (honey, propolis, Pelargonium sidoides extract, and zinc) plus standard of care showed statistically significant better performance than standard of care alone for throat pain, erythema, and swallowing scores. However, the open-label trial design and multi-ingredient nature of the preparation limit conclusions about honey's independent contribution. Evidence for honey in sore throat/tonsil contexts is rated preliminary to moderate, primarily because trials are of combination formulations and not honey in isolation.

Garlic (Allium sativum)

Traditional Use: Garlic has been used for millennia across ancient Egyptian, Greek, Roman, and Asian traditions for its antimicrobial and immunostimulant properties, including for throat and respiratory complaints. Raw garlic, garlic decoctions, and garlic-infused preparations have all featured in traditional pharmacopeias.

Scientific Evidence: Allicin, an organosulfur compound obtained from garlic, was highly effective in one small trial for prevention of the common cold. Garlic was among the eight ingredients for which peer-reviewed literature met eligibility criteria for systematic review on immune-health supplement claims. Evidence for garlic's effect on tonsil-specific disease is limited and indirect. The overall evidence for garlic in upper respiratory infections is rated preliminary, based primarily on small or single trials, and tonsil-specific clinical data are absent.

Summary Table: Evidence Strength by Ingredient

• Vitamin D: Observational association with recurrent tonsillitis consistently found across multiple case-control studies and a systematic review of 11 studies (2,503 participants); RCT-level confirmation for tonsillitis-specific supplementation benefit not yet established. Evidence strength: moderate-observational.
• Zinc: Moderate-quality RCT evidence for reducing cold duration when taken within 24 hours of symptom onset; one combination-product tonsillitis RCT showed benefit. Evidence strength: moderate (upper respiratory illness context), preliminary (tonsil-specific).
• Vitamin C: Consistent evidence for modest reduction in cold duration; no tonsillitis-specific RCTs. Evidence strength: moderate (cold context), insufficient (tonsil-specific).
• Echinacea: Most consistent for treatment (not prevention) of upper respiratory tract infections; best data for E. purpurea; no tonsil-specific RCTs. Evidence strength: preliminary to moderate.
• Elderberry: Preliminary RCT-level data for cold symptom reduction; no tonsil-specific data. Evidence strength: preliminary.
• Propolis: Preliminary clinical trial data in tonsillopharyngitis, primarily open-label and combination products. Evidence strength: preliminary.
• Honey: Preliminary data in sore throat and combination tonsillitis trials; mechanisms include antimicrobial and anti-inflammatory properties. Evidence strength: preliminary.
• Garlic: One small prevention trial; largely in vitro and animal data for antimicrobial mechanisms. Evidence strength: preliminary.

References

• StatPearls: Anatomy, Head and Neck: Tonsils — NCBI Bookshelf
• Arambula A et al. Anatomy and physiology of the palatine tonsils, adenoids, and lingual tonsils. World J Otorhinolaryngol Head Neck Surg. 2021. PMC8356106
• Hellings P et al. The Waldeyer's ring. PubMed 11082757
• Unveiling the Enigmatic Adenoids and Tonsils: Exploring Immunology, Physiology, Microbiome Dynamics — MDPI Microorganisms, 2023
• Medicine LibreTexts: 19.4C Tonsils
• TeachMeAnatomy: The Tonsils (Waldeyer's Ring)
• Cleveland Clinic: Tonsils — Anatomy, Definition & Function
• Mayo Clinic: Tonsillitis — Symptoms & Causes
• StatPearls: Peritonsillar Abscess — NCBI Bookshelf
• AAFP: Tonsillectomy in Children — AAO–HNS Updates Guideline. Am Fam Physician. 2019
• AAFP: AAO–HNS Guidelines for Tonsillectomy in Children and Adolescents. Am Fam Physician. 2011
• American Academy of Otolaryngology–Head and Neck Surgery: Clinical Indicators for Tonsillectomy
• Vitamin D Levels in Children with Recurrent Acute Tonsillitis in Jordan: A Case-Control Study. PMC9317687
• Yildiz I et al. The role of vitamin D in children with recurrent tonsillopharyngitis. Ital J Pediatr. 2012. PMC3453523
• Is There any Association between Vitamin D Deficiency and Recurrent Tonsillopharyngitis? An Updated Systematic Review. PMC11079729
• Rondanelli M et al. Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and Echinacea. Evid Based Complement Alternat Med. 2018. PMC5949172
• Select Dietary Supplement Ingredients for Preserving and Protecting the Immune System in Healthy Individuals: A Systematic Review. PMC9655067
• Esposito et al. The Effectiveness of a Dietary Supplement with Honey, Propolis, Pelargonium sidoides Extract, and Zinc in Children Affected by Acute Tonsillopharyngitis. PMC11206353
• The Effects of Propolis on Viral Respiratory Diseases. PMC9824023
• Histopathological role of vitamin D deficiency in recurrent/chronic tonsillitis pathogenesis. PMC9209805
• Solitary tonsil causing severe obstructive sleep apnea. PubMed 23680524
• Efficacy of minimally invasive tonsil surgery for treatment of obstructive sleep apnea-hypopnea syndrome in children. PMC5441284
• EBSCO Research Starters: Tonsils — Anatomy and Physiology
• Wikipedia: Tonsil